Special Instruments Consortium (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 05-07-2024
- Paid Up Capital ₹ 0.20 M
as on 05-07-2024
- Company Age 15 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 63.58%
(FY 2019)
- Profit 289.09%
(FY 2019)
- Ebitda 263.48%
(FY 2019)
- Net Worth 51.86%
(FY 2019)
- Total Assets 33.55%
(FY 2019)
About Special Instruments Consortium (India)
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Ramgopal Sethuraman, Sasiprabha Sethuraman, and Sridevi Ramgopal serve as directors at the Company.
- CIN/LLPIN
U33130TN2009PTC072370
- Company No.
072370
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Jul 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Special Instruments Consortium (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sridevi Ramgopal  | Managing Director | 01-Apr-2019 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramgopal Sethuraman | Whole-Time Director | 23-Jul-2009 | Current |
| Sasiprabha Sethuraman | Director | 05-Sep-2009 | Current |
Financial Performance of Special Instruments Consortium (India).
Special Instruments Consortium (India) Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 63.58% increase. The company also saw a substantial improvement in profitability, with a 289.09% increase in profit. The company's net worth Soared by an impressive increase of 51.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Special Instruments Consortium (India)?
In 2019, Special Instruments Consortium (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Spinco Life Sciences (India) Private LimitedActive 15 years 5 months
Ramgopal Sethuraman, Sasiprabha Sethuraman and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Special Instruments Consortium (India)?
Unlock and access historical data on people associated with Special Instruments Consortium (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Special Instruments Consortium (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Special Instruments Consortium (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
